Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
Share
The office coordinates nationwide testing of new treatment approaches for cancer.
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
The Cybersecurity Nightmares Threatening Modern Organizations
Cybersecurity leaders examine the hidden threats facing organizations, from shadow AI and legacy systems to alert fatigue, analyst burnout and emerging AI risks.
17m watch -
Keeping Aging Federal Systems Running Amid OT Vulnerabilities
A techno-thriller novel highlights how organizational silos can become critical infrastructure vulnerabilities in the AI era.
19m watch -
HHS Looks to Centralize IT Buying, Speed Access to Emerging Tech
HHS is centralizing IT procurement while pursuing faster acquisition tools for AI and other emerging technologies.
9m watch -
VA Employees Save 6 Hours a Week With AI Tools
VA AI chief Kimberly McManus said AI tools are helping improve veteran care, reduce opioid overdose mortality and save time for employees.
4m watch
